Ahead of the European Elections in June 2024, EHPM calls on the EU to recognise food supplements as important allies for European citizens’ health, and to promote policies that empower consumers, and enable the continued growth of the European food supplement sector in the next mandate.
Panama is increasingly becoming the hub of illicit tobacco trade, costing the country massive loss of public revenues and at the same time, raising questions over the policy response to this phenomenon.
For the last three decades, the availability of cost-effective generic medicines has driven increased access to life-saving treatments for millions of patients in Europe. Today, generic medicines are an integral part of the healthcare system and demand for these products continues to increase worldwide.
The Companion Animals Stakeholder Summit was held in Brussels on 19th of March 2024 and aimed to bring stakeholders together to work on a common purpose: underscoring the need in the EU for greater cooperation and policy action for companion animals’ health and welfare.
As we approach the beginning of a new EU institutional cycle, marked by the election of a new European Parliament and the start of a new Commission mandate and European Council Strategic agenda for 2024-2029, the future of healthcare in Europe is at a crossroads.
Snus is a moist oral tobacco product with roots dating back to the 18th century. It is considered one of the first novel tobacco products as it took several centuries for other products, such as heated tobacco, electronic cigarettes or nicotine pouches, to emerge on the market as alternatives to cigarettes.
Snus is a moist oral tobacco product with roots dating back to the 18th century
In April 2023, the European Commission adopted a proposal for a new Directive and a new Regulation, aimed at revising and replacing the existing General Pharmaceutical Legislation (GPL).
Health and climate policy experts converged in Milan to participate at a roundtable event organised by Chiesi. The purpose of the event was to discuss the findings of a new survey, part of a report published by Economist Impact and …
*Content-Type: Underwritten / Supported Compared to Europe, Japan has stricter smoking restrictions - in outdoor public spaces and then indoor environments too. The high population density and the traditional Japanese principle of respecting their fellow citizens explain why the smell of a …
New genomic techniques (NGTs) and their products have been rapidly developing in the last 20 years in many parts of the world, with some applications already on the market of some EU trade partners. On 5 July 2023, the European Commission …
Cannabis, the most consumed illicit drug in the EU, is sparking a heated debate across Europe. Join us as we dive into the recent groundbreaking German proposal to regulate recreational cannabis use. Explore how different EU countries view cannabis and compare …
Join us for an event that brings together a diverse group of rare disease experts to discuss and propose policy recommendations for improving the European legislative framework for orphan drugs. With a focus on collaboration and consensus-building, this event is meant to create a meaningful dialogue and help chart a path forward for a more effective legislative and regulatory framework, capable of addressing the needs of people with rare conditions and boosting innovation.
Established in 2020, the European Expert Group on Orphan Drug Incentives (OD Expert Group) is a multidisciplinary and cross-functional expert group that brings together representatives of the broad rare disease community, including researchers, academia, patient representatives, members of the investor community, rare disease companies and trade associations. Our experts and representatives of the decision-making processes will explore ideas for navigating the challenges ahead, trying to address the question of how to create a resilient ecosystem for rare diseases.
Organised by: The European Expert Group on Orphan Drug Incentives (OD Expert Group) Media Partner: EURACTIV
To raise awareness of the urgent need to adopt recent evidence-based recommendations in the management of T2D, IDF Europe is launching a new publication: “Type 2 Diabetes: a preventable catastrophe?”.
During the launch event, panellists representing academia, healthcare professionals, people living with T2D, industry and policy makers will discuss why we urgently need to adjust our healthcare systems across Europe and remove the barriers that are preventing early and tight management of T2D and its associated risk factors.
We would never accept three jumbo jets falling from European skies every single day… we can simply not accept the same number of people (half a million in 2021) dying prematurely every day in Europe because of preventable diabetes-related complications. We can do something about that. And we must.
Rewatch the conversation and learn more about our call to action on June 6!
Organiser: International Diabetes Federation Europe Supporter: Lilly Diabetes Media Partner: EURACTIV
Rewatch this EURACTIV Hybrid Conference to find out how to empower transplant patients, facilitating a meaningful dialogue between organ donors and their families, caregivers and transplant professionals. Discussed questions included: - How can different stakeholders partner and not work in silos in order to improve the overall healthcare system and positively impact patient outcomes? - How can transplantation be encouraged and included more in the global health discussion? - How can we reduce the gaps for people who are waiting for a transplant? - How can the shortage of available organs be overcome?
>> Click here for more information about the event.
>> Click here to check out our upcoming events.
The new agency, which will start working in January 2024, will assess the health and security threats related to illicit drugs across the European Union. What exactly will be its responsibilities and how will it work?
The International Fragrance Association’s (IFRA) mission is to promote the essential nature of fragrance – to maintain the highest standards of safety in the manufacture and use of fragrance materials – and to reinforce a sustainable, science-based fragrance ecosystem.
Rewatch this EURACTIV Hybrid Conference to learn the role of research and innovation in the healthcare sector, most notably in fighting health inequalities. Discussed questions included:
- What are the biggest health inequalities and consequent challenges across the EU? How are different Member States tackling them? - How have new technologies helped achieve notable improvements at local level? - In which ways can innovations in diagnosis contribute to strengthening the health of individuals and communities while combating inequalities? - What have we learned from Covid-19 in fighting inequalities?
Rewatch this EURACTIV Virtual Conference to find out the probiotics sector, its challenges and opportunities, and how increased clarity can benefit European industry while providing better information and transparency for consumers.
Thought Leadership, in conversation with… John J. Trizzino, Novavax Executive Vice President, Chief Commercial Officer, and Chief Business Officer.
Violence against women remains a major social problem, worldwide and across the EU. In an effort to take active prevention, GOALSCORE and its partners believe sports and more specifically football, can play an important role in tackling gender violence among …
Philippe Drechsle, Chair of the Manufacturing committee at Medicines for Europe shares his vision to achieve open strategic autonomy for manufacturing of essential medicines in Europe. Reform is coming to the EU pharmaceutical legislation and Medicines for Europe is calling for …
Rewatch this EURACTIV Hybrid Conference to find out the potential of adult immunisation to fight vaccine-preventable diseases and the pressure such programmes would have on our healthcare systems.
